Envestnet Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.09M Buy
15,461
+89
+0.6% +$42.5K ﹤0.01% 1975
2025
Q4
$8.95M Buy
15,372
+806
+6% +$412K ﹤0.01% 1770
2025
Q3
$6.68M Buy
14,566
+64
+0.4% +$23.9K ﹤0.01% 2036
2025
Q2
$4.39M Sell
14,502
-768
-5% -$229K ﹤0.01% 2276
2025
Q1
$5.06M Buy
15,270
+269
+2% +$88.4K ﹤0.01% 2117
2024
Q4
$4.63M Buy
15,001
+334
+2% +$93.9K ﹤0.01% 2154
2024
Q3
$3.11M Buy
14,667
+213
+1% +$54.5K ﹤0.01% 2392
2024
Q2
$4.05M Buy
14,454
+9,616
+199% +$2.29M ﹤0.01% 2169
2024
Q1
$1.29M Sell
4,838
-103
-2% -$24.3K ﹤0.01% 2855
2023
Q4
$1.14M Buy
4,941
+708
+17% +$124K ﹤0.01% 2842
2023
Q3
$618K Buy
4,233
+1,981
+88% +$373K ﹤0.01% 3135
2023
Q2
$520K Buy
2,252
+432
+24% +$117K ﹤0.01% 3183
2023
Q1
$441K Buy
1,820
+539
+42% +$147K ﹤0.01% 3226
2022
Q4
$372K Buy
+1,281
New +$125K ﹤0.01% 3283
2013
Q4
Sell
-58
Closed -$13K 2514
2013
Q3
$13K Buy
+58
New +$12.3K ﹤0.01% 1614

Other funds holding MDGL